Introducing the OcuCheck™ Biosensor
The OcuCheck is a revolutionary point of care device designed to provide unparalled precision in tear fluid analysis.
​
The core technology of our sensor allows for superior data analytics to guide disease diagnosis and management.
Our platform technology is the first to deliver a quantitative, immediate result of tear fluid proteins.
​
qUANTITATIVE dIAGNOSTICS
A Quantitative Measurement Tear Fluid Biomarkers. Provides Results within Minutes with Superior Core Technology.
pERSONALIZED treatment solutions
An Objective Measurement Can Be Used To Standardize And Classify Different Forms Severity of Disease
INNOVATIVE PLATFORM TECHNOLOGY
First Multiplex Platform Technology for Tear Fluid. Tested in More than Eight Tear Fluid Proteins to Diagnose Conditions from Dry Eye to Diabetes
ABOUT US
ADVANCING TEAR FLUID ANALYTICS
Our company is dedicated to translational research initiatives that will advance diagnostics and evaluation of eye and systemic disease. Our primary focus is to provide an objective measurement of tear fluid biomarkers to standardize treatment solutions not only for dry eye but for systemic disease. We are an innovative tear fluid analytic company enabling detection of hard to diagnose diseases by collecting and analyzing tear fluid in a non-invasive way.
OUR FOCUS
IMPROVING ACCESS TO CARE
Improving Screening of Diabetes
34% of diabetic patients are diagnosed during a visit to their optometrists. The OcuCheck can provide optometrists with additional tools that can accurately measure systemic sugar control can identify additional patients at risk for diabetic eye complications.
​
Improving Testing for Diabetes
1 out of every 7 diabetic patients are not compliant with their required annual testing or home sugar monitoring. The OcuCheck would address this unmet need for a noninvasive method to measure blood sugar control in the office or at home.
​
Improving Management of Dry Eye
Patients with dry eye see 2-3 doctors before obtaining a proper diagnosis of their condition. The OcuCheck can provide an objective measurement of tear fluid biomarkers to diagonse dry eye on the first visit.
INNOVATION
The OcuCheck is a point-of-care device that uses a specialized electrochemical sensor with proprietary coatings to measure specific biomarkers present in the tear fluid. Currently, the OcuCheck is the only device that can simultaneously measure MMP-9 and tear film osmolarity in one device. It is also one of the most accurate devices for quantitative measurement of MMP-9.
​
The OcuCheck device is lightweight, portable, and durable so that it can be used outside of a clinical setting.
NEWSROOM
